Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Randomised EORTC head and neck cooperative group trial of preoperative intra-arterial chemotherapy in oral cavity and oropharynx carcinomaJ M Richard, A Kramar, R Molinari, et al.
Head & Neck|September 1, 1995
Epilarynx: pharynx or larynx?J L Lefebvre, E Buisset, B Coche-Dequeant, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Platinum concentration in human tumors of head and neck, uterine cervix, and breast following treatment with cisplatinB Hecquet, P Vennin, C Fournier, et al.
European Journal of Cancer (Oxford, England : 1990)|September 30, 2004
French version of FACT-G: validation and comparison with other cancer-specific instrumentsT Conroy, M Mercier, J Bonneterre, et al.
American Journal of Surgery|October 1, 1993
Composite resection with mandibulectomy in the treatment of posterolateral oral cavity and lateral oropharynx squamous cell carcinomaJ L Lefebvre, B Vankemmel, B Prevost, et al.
International Journal of Oral and Maxillofacial Surgery|November 21, 2007
Additional direct medical costs associated with nosocomial infections after head and neck cancer surgery: a hospital-perspective analysisN Penel, J-L Lefebvre, J L Cazin, et al.
Cell Death & Disease|May 22, 2015
Necrosis- and apoptosis-related Met cleavages have divergent functional consequencesR Montagne, M Berbon, L Doublet, et al.
International Journal of Oral and Maxillofacial Surgery|March 18, 2008
Prognostic factors for adult sarcomas of head and neckN Penel, Y Mallet, Y-M Robin, et al.
The European Respiratory Journal|June 11, 2011
Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3I Borget, J Cadranel, J-P Pignon, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2004
Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer; a phase II trial of the EORTC-New Drug Development GroupG Giaccone, E F Smit, M de Jonge, et al.
Pageof 10